Mark Dawson, MD
Pediatrics · Rayne, LANPI 1043210271
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $754 and has fallen 57.6% since, to $320 in 2025. Among pediatrics clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$387
- Amgen$272
- AbbVie$244
- GSK$195
- Merck$194
- Corium, LLC$133
- plus $2K from 32 others
What the payments were for
- Food & beverage$2,942100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 27 | $387 |
| Amgen | 19 | $272 |
| AbbVie(2 entities) | 10 | $244 |
| GSK | 11 | $195 |
| Merck | 13 | $194 |
| Corium, LLC | 9 | $133 |
| Novo Nordisk | 9 | $131 |
| Johnson & Johnson | 3 | $127 |
| Tris Pharma Inc | 1 | $125 |
| AstraZeneca | 8 | $112 |
| Novartis | 7 | $100 |
| Ironshore Pharmaceuticals Inc. | 6 | $94 |
| Exact Sciences | 4 | $75 |
| Ultragenyx Pharmaceutical Inc. | 1 | $67 |
| Amarin Pharma, Inc. | 4 | $52 |
| Sanofi Pasteur Inc. | 4 | $52 |
| Abbott | 3 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Pfizer | 3 | $46 |
| Bayer | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Seqirus USA Inc | 2 | $33 |
| Radius Health, Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Alvogen Inc | 1 | $19 |
| Bioventus LLC | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Biogen | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Sarepta Therapeutics, Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$125
- XARELTO$110
How this compares
$2,942 in reported general payments places this provider in the 90th percentile of 913 pediatrics providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 106 | $108,154 |
| JardianceEmpagliflozin | 116 | $91,450 |
| EliquisApixaban | 146 | $89,993 |
| JanuviaSitagliptin Phosphate | 95 | $61,099 |
| LinzessLinaclotide | 82 | $50,140 |
| XareltoRivaroxaban | 72 | $43,603 |
| OzempicSemaglutide | 30 | $36,219 |
| MounjaroTirzepatide | 29 | $34,750 |
| LybalviOlanzapine/Samidorphan Malate | 17 | $27,928 |
| TrintellixVortioxetine Hydrobromide | 47 | $23,627 |
| FarxigaDapagliflozin Propanediol | 20 | $17,555 |
| ViberziEluxadoline | 11 | $17,331 |
| EntrestoSacubitril/Valsartan | 21 | $16,703 |
| MyrbetriqMirabegron | 32 | $15,880 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $13,020 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $387 | $142,904135 claims |
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Combivent Respimat | $20 | $109,016149 claims |
| PfizerEliquis | $46 | $89,993146 claims |
| AbbVieLinzess, Viberzi | $244 | $67,47193 claims |
| MerckJanuvia | $194 | $61,09995 claims |
| Johnson & JohnsonXarelto | $127 | $43,60372 claims |
| Novo NordiskOzempic | $131 | $36,21930 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $15 | $23,62747 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $195 | $22,31633 claims |
| AstraZenecaFarxiga | $112 | $17,55520 claims |
| NovartisEntresto | $100 | $16,70321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 913 pediatrics providers in Louisiana.
Other pediatrics in Rayne
- Corey HebertGretna$1.3M
- Katie QueenBogalusa$61K
- Elizabeth WhiteCovington$19K
- Neslihan GungorShreveport$16K
- Amy VitteLafayette$10K
- Alicia NicklasLafayette$9K
- Paul YuratichNew Orleans$9K
- Catherine SpillerWalker$8K
- Mamatha MandavaShreveport$8K
- Caroline KlineBaton Rouge$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.